BMEZ Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 0.17%, SMA50 -0.65%, SMA200 2.66%). The stock’s 14-day RSI is 49.03 (neutral), while the ATR of 0.19 points to moderate volatility. The stock remains hovering near 52-week lows, trading -5.69% below its high and over 19.95% above its low. Average 10-day trading volume of 185.77 thousand shares is in line with the 3-month average of 184.47 thousand, indicating normal recent market interest.

BlackRock Health Sciences Term Trust last paid a dividend of 1.49 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $3.09. This means the shares are trading above this model’s fair value.

Our AI price prediction model suggests that BlackRock Health Sciences Term Trust stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

currently trading near 52-week highs band. Valuation shows BlackRock Health Sciences Term Trust trading at a premium to the broader market with a P/E of 8.61.

BlackRock Health Sciences Term Trust (NYSE:BMEZ) closed at $15.23 USD, gaining $0.02 (0.13%) from the previous close of $15.21. The stock is currently within 5% of its 52-week high $13.67 and $15.80. With a market capitalization of about $1.54 billion, BlackRock Health Sciences Term Trust is classified as a small-cap and shows market-like volatility (beta ~0.85). Key stats such as the average daily volume over the past year has been around 188.03 thousand shares, volume is running light vs its 52-week average. Headquartered in New York, NY, BlackRock Health Sciences Term Trust operates in the Financial Services sector and the Asset Management industry. BlackRock Health Sciences Term Trust is a closed-end management investment company, which investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation.

BlackRock Health Sciences Term Trust trades at a P/E ratio of 8.61, slightly below the S&P 500 average, with a price-to-sales ratio of 64.11 and a price-to-book ratio of 0.26 suggesting the stock is closer to book value. The P/FCF stands at 23.55, also below market averages.